Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Selling, General & Administrative (2018 - 2026)

Updated

Moderna (MRNA) reported Selling, General & Administrative of $216 million for Q2 2026, down 6.1% from $230 million a year earlier but up 24.9% from the prior quarter.

Analysis

Moderna (MRNA) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Moderna's Selling, General & Administrative came in at $965 million, down 10.1% year-over-year; for FY2025, it was $1.02 billion, down 13.3% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 40.2% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $1.17 billion in FY2024 (-24.2%), $1.55 billion in FY2023 (+36.8%), $1.13 billion in FY2022 (+99.6%) and $567 million in FY2021 (+201.6%).
  • Five-year quarterly Selling, General & Administrative spans a low of $168 million in Q3 2021 and a high of $470 million in Q4 2023.
  • Year over year, Selling, General & Administrative has now declined in each of the last ten quarters, with an average decline of 17.5% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q3 2021 (growth of 250.0%); the low point was Q3 2024 (a decline of 36.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $173 million (Q1 2026), $308 million (Q4 2025) and $268 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 6.43 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.63 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 5.65 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 1.92 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 3.41 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn 216.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 216.00 Mn
Mar 31, 2026 173.00 Mn
Dec 31, 2025 308.00 Mn
Sep 30, 2025 268.00 Mn
Jun 30, 2025 230.00 Mn
Mar 31, 2025 212.00 Mn
Dec 31, 2024 351.00 Mn
Sep 30, 2024 281.00 Mn
Jun 30, 2024 268.00 Mn
Mar 31, 2024 274.00 Mn
Dec 31, 2023 470.00 Mn
Sep 30, 2023 442.00 Mn
Jun 30, 2023 332.00 Mn
Mar 31, 2023 305.00 Mn
Dec 31, 2022 375.00 Mn
Sep 30, 2022 278.00 Mn
Jun 30, 2022 211.00 Mn
Mar 31, 2022 268.00 Mn
Dec 31, 2021 201.00 Mn
Sep 30, 2021 168.00 Mn
API Access

Moderna Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MRNA&period=max&api_key=YOUR_API_KEY